XML 53 R15.htm IDEA: XBRL DOCUMENT
v3.22.4

Share-Based Awards, Purchase Plans and Compensation Cost | 12 Months Ended
--- | ---
Dec. 30, 2022
Share-based Payment Arrangement [Abstract] |
Share-Based Awards, Purchase Plans and Compensation Cost | Share-Based Awards, Purchase Plans and Compensation Cost Stock Option and Award Plan. The Company has a stock incentive plan under which it grants stock options and share awards to directors, officers and other employees. Option price is the market price on the date of grant. Options become exercisable at such time, generally over 3 years or 4 years, and in such installments as set by the Company, and expire 10 years from the date of grant. Restricted share awards have been made to certain key employees under the plan. The market value of restricted stock at the date of grant is charged to operations over the vesting period. Compensation cost related to restricted shares is not significant. The Company has a stock appreciation plan that provides for payments of cash to eligible foreign employees based on the change in the market price of the Company’s common stock over a period of time. Compensation cost related to the stock appreciation plan was a benefit of $0.2 million in 2022, and expense of $3.1 million in 2021 and $2.4 million in 2020. Individual nonemployee directors of the Company may elect to receive, either currently or deferred, all or part of their retainer in the form of shares of the Company’s common stock instead of cash. Under this arrangement, the Company issued 12,055 shares in 2022, 12,070 shares in 2021 and 15,243 shares in 2020. The expense related to this arrangement is not significant. Options on common shares granted and outstanding, as well as the weighted average exercise price, are shown below (in thousands, except exercise prices):
| Option Shares |  | Weighted Average Exercise Price |  | Options Exercisable |  | Weighted Average Exercise Price
Outstanding, December 27, 2019 | 12,112 |  |  | $ | 28.91 |  |  | 8,231 |  |  | $ | 23.75 |
Granted | 1,400 |  |  | 55.26 |  |  |  |  |
Exercised | (3,238) |  |  | 20.81 |  |  |  |  |
Canceled | (66) |  |  | 41.24 |  |  |  |  |
Outstanding, December 25, 2020 | 10,208 |  |  | 35.02 |  |  | 6,553 |  |  | 28.02 |
Granted | 843 |  |  | 72.22 |  |  |  |  |
Exercised | (1,309) |  |  | 24.91 |  |  |  |  |
Canceled | (167) |  |  | 55.59 |  |  |  |  |
Outstanding, December 31, 2021 | 9,575 |  |  | 39.31 |  |  | 7,296 |  |  | 33.75 |
Granted | 1,381 |  |  | 71.03 |  |  |  |  |
Exercised | (645) |  |  | 25.58 |  |  |  |  |
Canceled | (46) |  |  | 49.42 |  |  |  |  |
Outstanding, December 30, 2022 | 10,265 |  |  | $ | 44.40 |  |  | 7,793 |  |  | $ | 37.22 |
The following table summarizes information for options outstanding and exercisable at December 30, 2022 (in thousands, except exercise prices and contractual term amounts):
|  | Options Outstanding |  | Options Exercisable
Range of Prices |  | Options Outstanding |  | Weighted Average Remaining Contractual Term in Years |  | Weighted Average Exercise Price |  | Options Exercisable |  | Weighted Average Exercise Price
$10 - $30 |  | 2,971 |  |  | 2.4 |  | $ | 24.76 |  |  | 2,971 |  |  | $ | 24.76 |
$30 - $45 |  | 2,317 |  |  | 4.7 |  | 36.88 |  |  | 2,255 |  |  | 36.67 |
$45 - $60 |  | 2,813 |  |  | 6.6 |  | 50.50 |  |  | 2,325 |  |  | 50.02 |
$60 - $75 |  | 2,164 |  |  | 9.0 |  | 71.47 |  |  | 242 |  |  | 72.15 |
$10 - $75 |  | 10,265 |  |  | 5.5 |  | $ | 44.40 |  |  | 7,793 |  |  | $ | 37.22 |
The aggregate intrinsic value of exercisable option shares was $235.3 million as of December 30, 2022, with a weighted average contractual term of 4.5 years. There were approximately 10.3 million vested share options and share options expected to vest as of December 30, 2022, with an aggregate intrinsic value of $243.8 million, a weighted average exercise price of $44.40 and a weighted average contractual term of 5.5 years. Information related to options exercised follows (in thousands):
| 2022 |  | 2021 |  | 2020
Cash received | $ | 15,739 |  |  | $ | 32,610 |  |  | $ | 66,625 |
Aggregate intrinsic value | 28,193 |  |  | 65,319 |  |  | 120,395 |
Tax benefit realized | 6,020 |  |  | 13,329 |  |  | 25,000 |
Employee Stock Purchase Plan. Under the Company’s Employee Stock Purchase Plan, the purchase price of the shares is the lesser of 85 percent of the fair market value on the first day or the last day of the plan year. Under this plan, the Company issued 316,250 shares in 2022, 415,995 shares in 2021 and 399,567 shares in 2020. Authorized Shares. In April 2019, shareholders of the Company approved the Graco Inc. 2019 Stock Incentive Plan. The Plan provides for issuance of up to 10 million shares of Graco common stock. Shares authorized for issuance under the stock option and purchase plans are shown below (in thousands):
| Total Shares Authorized |  | Available for Future Issuance as of December 30, 2022
Stock Incentive Plan (2019) | 10,000 |  |  | 5,790 |
Employee Stock Purchase Plan (2006) | 21,000 |  |  | 11,763 |
Total | 31,000 |  |  | 17,553 |
Amounts available for future issuance exclude outstanding options. Options outstanding as of December 30, 2022, include options granted under two plans that were replaced by subsequent plans. No shares are available for future grants under those plans. Share-based Compensation. The Company recognized share-based compensation cost as follows (in thousands):
| 2022 |  | 2021 |  | 2020
Share-based compensation | $ | 24,695 |  |  | $ | 24,931 |  |  | $ | 25,153 |
Tax benefit | 2,319 |  |  | 1,705 |  |  | 1,700 |
Share-based compensation, net of tax | $ | 22,376 |  |  | $ | 23,226 |  |  | $ | 23,453 |
As of December 30, 2022, there was $17.4 million of unrecognized compensation cost related to unvested options, expected to be recognized over a weighted average period of approximately 2.7 years. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions and results:
| 2022 |  | 2021 |  | 2020
Expected life in years | 6.4 |  | 7.5 |  | 7.5
Interest rate | 2.7 | % |  | 0.9 | % |  | 1.4 | %
Volatility | 26.2 | % |  | 25.2 | % |  | 22.0 | %
Dividend yield | 1.2 | % |  | 1.0 | % |  | 1.3 | %
Weighted average fair value per share | $ | 19.10 |  |  | $ | 17.87 |  |  | $ | 12.18 |
Expected life is estimated based on vesting terms and exercise and termination history. Interest rate is based on the U.S. Treasury rate on zero-coupon issues with a remaining term equal to the expected life of the option. Expected volatility is based on historical volatility over a period commensurate with the expected life of options. The fair value of employees’ purchase rights under the Employee Stock Purchase Plan was estimated on the date of grant. The benefit of the 15 percent discount from the lesser of the fair market value per common share on the first day and the last day of the plan year was added to the fair value of the employees’ purchase rights determined using the Black-Scholes option-pricing model with the following assumptions and results:
| 2022 |  | 2021 |  | 2020
Expected life in years | 1.0 |  | 1.0 |  | 1.0
Interest rate | 0.9 | % |  | 0.1 | % |  | 1.5 | %
Volatility | 20.5 | % |  | 40.1 | % |  | 21.9 | %
Dividend yield | 1.2 | % |  | 1.1 | % |  | 1.4 | %
Weighted average fair value per share | $ | 16.01 |  |  | $ | 21.50 |  |  | $ | 11.55 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration